U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT07516769) titled 'Nicorandil as Anti-inflammatory in Rheumatoid Arthritis' on April 01.
Brief Summary: This study aims to evaluate the possible efficacy and safety of nicorandil as anti-inflammatory in managing patients with active rheumatoid arthritis.
Study Start Date: April, 2026
Study Type: INTERVENTIONAL
Condition:
Rhumatoid Arthisis
Intervention:
DRUG: Nicorandil 10 MG Oral Tablet
Nicorandil 10 MG Oral Tablet
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Tanta University
Information provided by (Responsible Party): Karim Abu El Fath Hussein Abd El Hakim, Tanta University
Published by HT Digital Content Services with permission from...